Ariane M. Horn

HHS-OIG Rule Expands Opportunities For Advisory Opinions

Biden Administration Issues Rules Requiring Insurer Transparency On Drug Spending, Rebates And Fees: What Manufacturers Need To Know

Pharmacy Point-Of-Sale Price Concession And PBM Service Fee Safe Harbor Final Rule May Reshape Medicare Part D: What Pharmaceutical Manufacturers Need To Know Now

Navigating Patient Needs Remotely: Addressing Challenges In Patient Access

HHS Proposes New Protections For Value-Based Arrangements And Other Revisions To AKS Safe Harbors, CMP Exceptions And Stark Exceptions

HHS OIG's Proposed Rule: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals